Epinephrine News and Research

RSS

New study launched to evaluate experimental treatment for food allergy

Though food allergy affects more than 4.8 million children in the United States, no approved preventative treatments currently exist.

2 Aug 2019

Treatment guidelines for managing anaphylaxis in children need to be reassessed

Treatment guidelines for managing anaphylaxis in children should be reassessed, according to a new Canadian study published in the Journal of Allergy and Clinical Immunology: In Practice.

31 May 2019

Fetal exposure to nicotine linked with SIDS and cardiac arrhythmias in newborns

Fetal exposure to tobacco smoke in utero is associated with sudden infant death syndrome (SIDS) and cardiac arrhythmias in newborns. In a novel study in rabbits, investigators provide the first evidence linking fetal exposure to nicotine to long-term alterations of the cardiac sodium current.

29 Mar 2019

Sphingotec reports new applications of bio-ADM at 39th ISICEM

Diagnostics company sphingotec GmbH reports novel applications of bio-ADM, the very first biomarker capable to diagnose the onset of septic shock, allowing physicians earliest life-saving therapeutic interventions in sepsis critical care.

20 Mar 2019

Regular dietary peanut consumption after immunotherapy may extend allergy treatment benefits

Regular dietary peanut consumption after completing oral immunotherapy or sublingual immunotherapy for peanut allergy may provide continued protection against accidental exposures to the allergen, according to a new study led by Edwin Kim, MD, who presented the findings at the annual American Academy of Allergy, Asthma and Immunology conference in San Francisco.

25 Feb 2019

Intense exercise, fasting and hormones can enhance waste-protein removal, study shows

The body's ability to adapt to changing conditions and shifting physiologic demands is essential to survival. To do so, each cell must be able to dispose of damaged or unnecessary proteins--a quality-control mechanism critical for cellular performance and for the health of the entire organism.

21 Feb 2019

New study establishes how stress favors breast cancer growth and spread

Cancer: The word alone evokes dread, anxiety, and fear. Accordingly, many women living with the disease and undergoing treatment experience chronic stress and depression.

19 Feb 2019

Sleep could be the best medicine to fight off an infection

Sleep has been underrated as the best medicine to fight off disease say researchers working on a new study. The study titled, “Gαs-Coupled Receptor Signaling and Sleep Regulate Integrin Activation of Human Antigen-Specific T Cells,” was published this week in the Journal of Experimental Medicine.

14 Feb 2019

Half of all food allergy sufferers are not actually allergic

A new study has shown that the food allergies that people claim to have may not be true. The study reveals that as many as 20 percent of Americans over the age of 18 years believe that they are allergic to one or more food items. The study finds that the actual number of people who have a food allergy is close to 10 percent of the population. They also show that one in 20 Americans had a diagnosed case of a food allergy.

7 Jan 2019

How physical activity decreases belly fat in humans

Some of you may have made a New Year's resolution to hit the gym to tackle that annoying belly fat. But have you ever wondered how physical activity produces this desired effect? A signaling molecule called interleukin-6 plays a critical role in this process, researchers report December 27 in the journal Cell Metabolism.

28 Dec 2018

Green space linked to reduced risk of heart disease and stroke

Researchers have shown that people who live in neighborhoods with denser greens paces may be at a lower risk of developing heart disease and stroke.

5 Dec 2018

New drug shows promise for treating people with peanut allergy

Controlled ingestion of peanut protein could help build tolerance in peanut allergy sufferers. Authors of a new study published in the New England Journal of Medicine say an oral immunotherapy drug they tested could be the first FDA-approved medication of its kind for people with peanut allergy.

19 Nov 2018

Takeda presents vedolizumab phase 3 VISIBLE 1 trial results for treatment of moderately to severely active ulcerative colitis

Takeda Pharmaceutical Company Limited today announced results from the phase 3 VISIBLE 1 clinical trial evaluating the efficacy and safety of an investigational subcutaneous formulation of the gut-selective biologic vedolizumab for maintenance therapy in adult patients with moderately to severely active ulcerative colitis who achieved clinical response* at week 6 following two doses of open-label vedolizumab intravenous induction therapy.

22 Oct 2018

Middlemen suppliers can increase drug prices and hospital bills, say Johns Hopkins researchers

Hospitals should be cautious of group purchasing organizations, or entities that act as middlemen between health care providers and manufacturers, says Martin Makary, M.D., M.P.H., a professor of surgery at the Johns Hopkins University School of Medicine.

19 Oct 2018

Mechanically ventilated patients treated with vasopressor may develop ICU-related weakness

At least 25 percent of critically ill patients who receive mechanical ventilation in intensive care units develop muscular weakness severe enough to impair their quality of life.

11 Sep 2018

Alternative devices can help when autoinjectors are unavailable

Autoinjectors are in especially high demand as the new school year begins. Reports of a shortage of EpiPens have been surfacing lately as parents attempt to stock up on the epinephrine autoinjectors for school, home, backpacks and grandma's house.

17 Aug 2018

FDA grants approval for first generic version of epinephrine auto-injector

The U.S. Food and Drug Administration today approved the first generic version of EpiPen and EpiPen Jr (epinephrine) auto-injector for the emergency treatment of allergic reactions, including those that are life-threatening (anaphylaxis), in adults and pediatric patients who weigh more than 33 pounds.

16 Aug 2018

New clinical trial examines use of adrenaline to treat cardiac arrests

A clinical trial of the use of adrenaline in cardiac arrests has found that its use results in less than 1% more people leaving hospital alive - but almost doubles the risk of severe brain damage for survivors of cardiac arrest.

19 Jul 2018

Most adults with allergies do not use prescribed epinephrine even in emergency situations

The most effective, life-saving treatment for a severe allergic reaction is epinephrine. Yet a new study shows in an emergency, 52 percent of adults with potentially life-threatening allergies didn't use the epinephrine auto-injectors they were prescribed.

21 Jun 2018

Researchers find enzyme responsible for aircraft noise-related vascular damage

In a recent study, scientists at the Department of Cardiology at the University Medical Center of Johannes Gutenberg University Mainz have identified an enzyme responsible for aircraft-related vascular damage.

14 Jun 2018